The global DNA diagnostics market is poised for remarkable expansion, with sales expected to reach USD 27,094.2 million in 2024 and a projected climb to USD 57,420.1 million by 2034. This growth ...

We recently published a list of 10 Most Promising Gene Editing Stocks to Buy According to Hedge Funds. In this article, we are going to take a look at where Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) ...

Explore how AI-powered MRIs, retinal scans, and biohacking tools aim to revolutionize health diagnostics and longevity.

The global DNA synthesis market is projected to grow by $6.5 billion from 2024 to 2028, driven by automation and demand for ...

Kiwi biotechnology company DNAiTECH has announced a NZ$1 million raise led by Sprout Agritech, with a $750k repayable grant ...

The global mitochondrial DNA market is on a promising trajectory, with an estimated valuation of USD 316.8 million in 2022. The market is expected to grow steadily at a CAGR of 7.5% from 2023 to 2033, ...

As part of ongoing efforts to enhance quality-assured testing options, the World Health Organization (WHO) has listed two ...

STONY BROOK, NY / ACCESSWIRE / October 30, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) ('Applied DNA' or the 'Company'), a leader in ...

Cepheid and Roche Diagnostics Tests Provide Rapid and Decentralized Detection Options as Mpox Cases Continue to Rise ...

Invest in Natera, Inc. and GeneDx Holdings Corp. for potential growth in the booming precision medicine market. Click for ...

Pangea Laboratory has partnered with Unilabs, a leading European provider of clinical laboratory testing and diagnostic ...